Changes in HbA1c and treatment in the second year following initiation of second-line therapy in people with type 2 diabetes: the global DISCOVER study

被引：0
|
作者：
Nicolucci, A. [1 ]
Chen, H. [2 ]
Fenici, P. [3 ]
Gomes, M. B. [4 ]
Saraiva, G. Luporini [2 ]
Medina, J. [5 ]
Pocock, S. [6 ]
Shestakova, M. V. [7 ]
Shimomura, I. [8 ]
Surmont, F. [9 ]
Tang, F. [10 ]
Vora, J. [11 ]
Watada, H. [12 ]
Khunti, K. [13 ]
Charbonnel, B. [14 ]
机构：
[1] Ctr Outcomes Res & Clin Epidemiol, Pescara, Italy
[2] AstraZeneca, Gaithersburg, MD USA
[3] AstraZeneca, Cambridge, England
[4] Rio de Janerio State Univ, Rio De Janeiro, Brazil
[5] AstraZeneca, Madrid, Spain
[6] London Sch Hyg & Trop Med, London, England
[7] Diabet Inst, Endocrinol Res Ctr, Moscow, Russia
[8] Osaka Univ, Grad Sch Med, Osaka, Japan
[9] AstraZeneca, Luton, Beds, England
[10] St Lukes Mid Amer Heart Inst, Kansas City, MO USA
[11] Royal Liverpool Univ Hosp, Liverpool, Merseyside, England
[12] Juntendo Univ, Grad Sch Med, Tokyo, Japan
[13] Univ Leicester, Leicester, Leics, England
[14] Univ Nantes, Nantes, France
来源：
DIABETOLOGIA | 2019年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
353
引用
收藏
页码：S176 / S177
页数：2
相关论文
共 50 条
  • [1] Changes in HbA1c and Treatment in the Second Year following Initiation of Second-Line Therapy in People with T2D-The Global DISCOVER Study
    Charbonnel, Bernard
    Chen, Hungta
    Cid-Ruzafa, Javier
    Fenici, Peter
    Gomes, Marilia B.
    Saraiva, Gabriela Luporini
    Medina, Jesus
    Nicolucci, Antonio
    Pocock, Stuart
    Shestakova, Marina V.
    Shimomura, Iichiro
    Sadikot, Shaukat M.
    Surmont, Filip
    Tang, Fengming
    Vora, Jiten
    Watada, Hirotaka
    Khunti, Kamlesh
    DIABETES, 2019, 68
  • [2] Individualised HbA1c targets in people with type 2 diabetes initiating second-line therapy: the global DISCOVER study
    Khunti, K.
    Chen, H.
    Cid-Ruzafa, J.
    Fenici, P.
    Gomes, M. B.
    Hammar, N.
    Kennedy, K. F.
    Pocock, S.
    Shestakova, M. V.
    Shimomura, I.
    Surmont, F.
    Ji, L.
    DIABETOLOGIA, 2018, 61 : S175 - S175
  • [3] Individualized HbA1c Targets in People with Type 2 Diabetes Initiating Second-Line Therapy-The Global DISCOVER Study
    Khunti, Kamlesh
    Chen, Hungta
    Cid-Ruzafa, Javier
    Fenici, Peter
    Gomes, Marilia B.
    Hammar, Niklas
    Kennedy, Kevin
    Kosiborod, Mikhail
    Pocock, Stuart
    Shestakova, Marina V.
    Shimomura, Iichiro
    Surmont, Filip
    Ji, Linong
    DIABETES, 2018, 67
  • [4] Quality of Life in People with Type 2 Diabetes following Initiation of Second-Line Therapy: DISCOVER
    Nicolucci, Antonio
    Chen, Hungta
    Cooper, Andrew
    Gomes, Marilia B.
    Ji, Linong
    Khunti, Kamlesh
    Kosiborod, Mikhail N.
    Leigh, Paul
    Ramirez, Larisa
    Shestakova, Marina V.
    Shimomura, Iichiro
    Siddiqui, Afrah
    Tang, Fengming
    Vora, Jiten
    Watada, Hirotaka
    Arnold, Suzanne V.
    DIABETES, 2020, 69
  • [5] Vascular events in patients with type 2 diabetes in the year following initiation of second-line therapy: the DISCOVER study
    Surmont, F.
    Chen, H.
    Cid-Ruzafa, J.
    Fenici, P.
    Gomes, M. B.
    Khunti, K.
    Pocock, S.
    Rathmann, W.
    Shestakova, M. V.
    Shimomura, I.
    Tang, F.
    Watada, H.
    Ji, L.
    Hammar, N.
    Kosiborod, M.
    DIABETOLOGIA, 2018, 61 : S562 - S562
  • [6] Changes in HbA1c and weight after initiation of second-line therapy in patients with type 2 diabetes in clinical practice
    Wilding, J. P. H.
    Godec, T.
    Khunti, K.
    Pocock, S.
    Fox, R.
    Smeeth, L.
    Blak, B.
    Clauson, P.
    Fenici, P.
    Hammar, N.
    Rigney, U.
    Medina, J.
    DIABETOLOGIA, 2017, 60 : S301 - S301
  • [7] Quality of life in people with type 2 diabetes in the 3 years following initiation of second-line therapy: The DISCOVER study
    Nicolucci, Antonio
    Chen, Hungta
    Cooper, Andrew
    Fenici, Peter
    Gomes, Marilia B.
    Hammar, Niklas
    Ji, Linong
    Khunti, Kamlesh
    Kosiborod, Mikhail
    Medin, Jennie
    Shestakova, Marina, V
    Shimomura, Iichiro
    Tang, Fengming
    Vora, Jiten
    Watada, Hirotaka
    Arnold, Suzanne, V
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 185
  • [8] HbA1c trajectories over 3 years in people with type 2 diabetes starting second-line glucose-lowering therapy: The prospective global DISCOVER study
    Bongaerts, Brenda
    Kuss, Oliver
    Bonnet, Fabrice
    Chen, Hungta
    Cooper, Andrew
    Fenici, Peter
    Gomes, Marilia B.
    Hammar, Niklas
    Ji, Linong
    Khunti, Kamlesh
    Medina, Jesus
    Nicolucci, Antonio
    Shestakova, Marina V.
    Watada, Hirotaka
    Rathmann, Wolfgang
    DIABETES OBESITY & METABOLISM, 2023, 25 (07): : 1890 - 1899
  • [9] Vascular Events in Patients with Type 2 Diabetes in the Year following Initiation of Second-Line Therapy-The DISCOVER Study
    Kosiborod, Mikhail
    Chen, Hungta
    Cid-Ruzafa, Javier
    Fenici, Peter
    Gomes, Marilia B.
    Khunti, Kamlesh
    Pocock, Stuart
    Rathmann, Wolfgang
    Shestakova, Marina V.
    Shimomura, Iichiro
    Surmont, Filip
    Tang, Fengming
    Watada, Hirotaka
    Ji, Linong
    Hammar, Niklas
    DIABETES, 2018, 67
  • [10] HbA1c <7.0% 6 Months after Initiation of Second-Line Therapy in Patients with Uncontrolled Type 2 Diabetes Is Associated with Good Glycemic Control at 3 Years: The DISCOVER Study
    Bonnet, Fabrice
    Chen, Hungta
    Cooper, Andrew
    Gomes, Marilia B.
    Ji, Linong
    Leigh, Paul
    Gutierrez, Larisa Ramirez
    Shestakova, Marina V.
    Shimomura, Iichiro
    Siddiqui, Afrah
    Tang, Fengming
    Vora, Jiten
    Watada, Hirotaka
    Khunti, Kamlesh
    DIABETES, 2020, 69
12345